Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)
Active, not recruiting · NCT02764541 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) | Carcinoma, Lobular, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast cancer, breast disorder, breast neoplasm, carcinoma, epithelial neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-06-23 | NCT02764541 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Pfizer | 431 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Dana-Farber at St. Elizabeth's Medical Center | Boston | United States | 1 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| DF/BWCC at Milford Regional Medical Center | Milford | United States | 4 |
| DF/BWCC in clinical affiliation with South Shore Hospital | South Weymouth | United States | 5 |
| Eastern Maine Medical Center | Brewer | United States | 5 |
| Lifespan | Providence | United States | 4 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| Stamford Hospital | Stamford | United States | 10 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |